News
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and aging are locked in a vicious circle: ...
1d
The Hearty Soul on MSNDeficiency in Key Vitamin Linked to Liver Disease
Fatty liver disease is one of the fastest-growing health concerns worldwide, impacting roughly 32% of people worldwide, according to a 2022 systematic review. It is closely tied to rising rates of ...
3d
MedPage Today on MSNAt Least 60% of Liver Cancers Tied to Preventable Risk Factors
Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...
2d
News Medical on MSNRising liver cancer rates highlight need for urgent action worldwide
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...
MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.
Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...
In fact, heart disease is the most common cause of death among people who have metabolic dysfunction-associated steatotic liver disease (MASLD) (previously known as non-alcoholic liver disease).
MASLD stands for metabolic dysfunction-associated steatotic liver disease, and it’s a liver condition related to metabolic health. Taking steps like following a balanced diet, staying physically ...
Hepatitis C virus (HCV) infection is highly associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD), with a diagnosis requiring the presence of ...
Noureddin N, Copur-Dahi N, Loomba R. Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024;59 Suppl 1 (Suppl 1):S41-S51. doi:10. ...
The stigma of liver disease is all too common, whether it’s MASLD or other ones, like cirrhosis. One study published in 2022 found that 69% of patients with MASLD said they were stigmatized in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results